Page last updated: 2024-12-06
bpde-ii
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Description
BPDE-II: structure given in first source; a DNA adduct [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 44468 |
| MeSH ID | M0195529 |
Synonyms (24)
| Synonym |
|---|
| benzo(a)pyrene, 7-beta,8-alpha-dihydroxy-9-beta,10-beta-epoxy-7,8,9,10-tetrahydro-, (-)-cis |
| benzo(a)pyrene, 7,8,9,10-tetrahydro-7-alpha,8-beta-dihydroxy-9-alpha,10-alpha-epoxy-, (-)-z- |
| brn 4356683 |
| (-)-bp-7-beta,8-alpha-diol-9-beta,10-beta-epoxide 1 |
| (-)-cis-7-beta,8-alpha-dihydroxy-9-beta,10-beta-epoxy-7,8,9,10-tetrahydrobenzo(a)pyrene |
| syn-(-)-benzo(a)pyrene-7,8-diol-9,10-oxide |
| bpde-ii |
| (-)-syn-benzo(a)pyrene-7,8-dihydrodiol-9,10-epoxide |
| ccris 794 |
| 63357-09-5 |
| 6b9y97b2j0 , |
| unii-6b9y97b2j0 |
| 58917-91-2 |
| benzo(a)pyrene-7,8-dihydrodiol 9,10-epoxide, syn-(-)- |
| (7r,8s,9r,10s)-(-)-syn-benzo(a)pyrene-7,8-diol 9,10-epoxide |
| benzo(10,11)chryseno(3,4-b)oxirene-7,8-diol, 7,8,8a,9a-tetrahydro-, (7r-(7.alpha.,8.beta.,8a.beta.,9a.beta.))- |
| syn-benzo(a)pyrene-7,8-diol-9,10-epoxide, (-)-trans- |
| syn-bpde, (-)- |
| benzo(10,11)chryseno(3,4-b)oxirene-7,8-diol, 7,8,8a,9a-tetrahydro-, (7r,8s,8ar,9as)- |
| (7r,8s,9r,10s)-7,8-dihydroxy-9,10-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene |
| (-)-syn-benzo[a]pyrene-7,8-dihydrodiol-9,10-epoxide |
| rel-(7r,8s,8ar,9as)-7,8,8a,9a-tetrahydrobenzo[1,12]tetrapheno[10,11-b]oxirene-7,8-diol |
| (3s,5r,6s,7r)-4-oxahexacyclo[11.6.2.02,8.03,5.010,20.017,21]henicosa-1(20),2(8),9,11,13(21),14,16,18-octaene-6,7-diol |
| DTXSID301033184 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (6)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 6 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||